Latest news with #NYHA
Cision Canada
3 days ago
- Health
- Cision Canada
Berlin Heals Announces Publication of Two-Year Clinical Outcomes of Cardiac Microcurrent Therapy in ESC Heart Failure USA
Study shows sustained improvements in heart failure symptoms and function following long-term C-MIC therapy ZUG, Switzerland, July 16, 2025 /CNW/ -- Berlin Heals, a pioneer in bioelectric medicine for the treatment of heart failure, is pleased to announce the publication of a new peer-reviewed study titled "Two-year outcomes of a cardiac microcurrent device in chronic heart failure: A first-in-human pilot study" in the ESC Heart Failure journal. The study presents the long-term follow-up of patients enrolled in the initial pilot trial of the Cardiac Microcurrent Implantable Device (C-MIC), designed to restore myocardial function in patients with chronic heart failure. This publication marks the first report of sustained clinical benefit following the discontinuation of active therapy—two years after initial device implantation. Study Summary The two-year follow-up evaluated the safety, durability, and efficacy of C-MIC therapy in seven patients with chronic heart failure (NYHA Class III, mean LVEF 31.7%). Patients who had completed the initial six-month pilot trial were reassessed for mortality, hospitalization rates, device-related adverse events, and functional status. Key findings include: No device-related adverse events were reported over the two-year period. LVEF improvements of +11.6% at 6 months were sustained at +12.6% two years after deactivation of the device. 6-minute walk distance (6MWD) improved by over 200 meters at 6 months and remained nearly +191 meters above baseline at two years. Improvements in NYHA functional class and SF-36 quality-of-life scores were maintained. Only one patient required C-MIC reactivation. "These findings offer important clinical insights into the long-term potential of C-MIC therapy," said Prof. Dragana Kosevic, the study's first author and Co-Principal Investigator. "What's most encouraging is that the improvements in cardiac function and patient well-being were sustained even after the device was deactivated, suggesting a disease-modifying effect." John Brumfield, CEO of Berlin Heals, added: "The publication of this study reinforces our confidence in microcurrent therapy as a transformative treatment for heart failure. These two-year results validate both the safety and long-lasting impact of C-MIC and set the stage for larger clinical trials." Berlin Heals is currently expanding its clinical development program, with the multicenter C-MIC III trial now underway in several European countries. To access the full publication in ESC Heart Failure, please visit
Business Upturn
11-07-2025
- Health
- Business Upturn
Landmark MyClip Procedure Performed at Gleneagles Hospital, Lakdikapul, Hyderabad
Gleneagles Hospital, Lakdikapul, Hyderabad, is proud to announce a landmark achievement in cardiac care with the successful completion of a MyClip procedure (Transcatheter Edge-to-Edge Repair – TEER) on a 75-year-old male patient. Business Wire India Gleneagles Hospital, Lakdikapul, Hyderabad, is proud to announce a landmark achievement in cardiac care with the successful completion of a MyClip procedure (Transcatheter Edge-to-Edge Repair – TEER) on a 75-year-old male patient. This intervention, performed under the expert leadership of Chief Cardiologist Dr. M. Sai Sudhakar, marks the first time this procedure has been conducted in the Telugu-speaking states of Telangana and Andhra Pradesh, and only the second such case in South India. The patient had been diagnosed with severe mitral regurgitation (MR), severe pulmonary arterial hypertension (PAH), and was experiencing NYHA Class IV heart failure symptoms. He presented with profound breathlessness and was unable to carry out even minimal physical activity. Given his high surgical risk and complex pulmonary profile, he was deemed unfit for conventional mitral valve replacement (MVR). The cardiac team, guided by Dr. M. Sai Sudhakar, performed the minimally invasive MyClip procedure using advanced transesophageal echocardiography and fluoroscopy. The procedure was conducted under conscious sedation, and the MyClip device was precisely deployed, resulting in an immediate reduction of mitral regurgitation from severe to mild. The patient exhibited a remarkable improvement in symptoms, moving from NYHA Class IV to Class II within just 24hours after the procedure. He is currently stable and under close follow-up, and significantly improved symptoms. Reflecting on this milestone, Dr. M. Sai Sudhakar commented, 'This case exemplifies how advanced structural heart interventions can transform outcomes for patients who have no other surgical options. Our team's expertise and commitment made it possible to offer a life-changing therapy to a patient previously considered inoperable.' In a significant development for accessibility and affordability, Dr. Sudhakar highlighted that earlier, such procedures relied on foreign-based devices that had to be imported at a cost of more than Rs. 45 lakh. Now, with the introduction of the Indian-made MyClip device, developed by an Indian company, this advanced therapy is much more affordable and cost-effective for the common man in our country. Ms Madhvi Khurana, Chief Administrator, Gleneagles Hospitals, Lakdikapul, added, 'Bringing the MyClip procedure to the Telugu states not only sets a new benchmark for cardiac care but also reinforces our mission to make the latest, most effective therapies accessible to our community. We are proud to lead the way in advanced, minimally invasive heart treatments.' This achievement highlights the life-saving potential of catheter-based structural heart interventions, especially for patients who are not candidates for open-heart surgery. It also reinforces Gleneagles Hospital, Lakdikapul, as a regional center of excellence in advanced cardiac care and minimally invasive therapies. Under Dr. M. Sai Sudhakar's leadership, the hospital's structural heart program continues to adopt the latest innovations in interventional cardiology, ensuring that these therapies are accessible to the common man as well. The hospital extends its sincere appreciation to the entire heart team, cath lab staff, and the anaesthesiology and critical care teams for their dedication and coordination in making this milestone possible. Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same. Ahmedabad Plane Crash
Yahoo
22-02-2025
- Business
- Yahoo
Bank CEO fights for small businesses in New York City
NEW YORK (PIX11) – From helping the director of a homeless shelter get repairs in her own home to talking one-one with the CEO of Ponce Bank, PIX11's Monica Morales is making it happen. It was back in September PIX11's Monica Morales visited Ponce Bank president and CEO Carlos Naudon. More Local News He received a $ 35 million check from the state to help Bronx small businesses survive and thrive. Naudon continues every day to fight for New York City's small businesses. He is a guest on the following Monica Makes Money Happen podcast. From humble beginnings coming to America when Naudon was just 13 years old from Chile, Naudon had nothing but a suitcase, and now he's the president of Ponce Bank. With assets of more than $3 billion. That's why Naudon says he fights so hard for small businesses. Naudon launched the Ponce Bank small business boot camp in 2020, helping 1400 small businesses not just survive but thrive. Another New Yorker spends her whole day fighting for homeless families to get better housing—she felt helpless to get repairs herself in her east Harlem home at the Wilson Houses. Shaday Harris sent us this video asking for help for her mom since our story action. NYHA crews were able to stop the leak and continue to work on the problem. If you have a problem, reach out to Monica Morales at monica@ Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Sign in to access your portfolio
